Title of Winning Proposal: Juvenile Bipolar Disorder: Making the Diagnosis.

Dr. Galanter, a Post-Graduate Child Psychiatry Research Fellow at Columbia University/New York State Psychiatric Institute, studies the relationship between attention deficit hyperactivity disorder (ADHD) and bipolar disorder in children. She has examined how children with ADHD and manic symptoms respond to stimulants, and whether ADHD youths are at increased risk for developing adult bipolar disorder. She is developing methods for improving physician medical education and helping physicians apply research advances to clinical practice. With this award she will use decision-making research to study how child psychiatrists diagnose bipolar disorder.

After earning her undergraduate degree from University of Pennsylvania and her medical degree from New York University School of Medicine, she completed General and Child Psychiatry Residencies at Columbia University. She is active in the American Psychiatric Association and is the Founding Chair of the Shire/APA Child Psychiatry Fellowship. She also serves on the Board of the New York Council of Child and Adolescent Psychiatry and the American Academy of Child and Adolescent Psychiatry's Work Group on Consumer Issues. She has received many national awards including APA's Lilly Resident Research Award and Aventis Travel Fellowship for Women Residents in Psychiatry and AACAP's Charter Behavioral Fellowship and Lilly Pilot Award.

International/Schizophrenia Category:

Michael Breakspear, MBBS, Ph.D.
Post-Doctoral Research Fellow
Brain Dynamic Centre
Westmead Hospital and School of Physics
Australia

Title of Winning Proposal: Multiscale Connectivity Analysis of Brain Function in Schizophrenia

Michael is a post-doctoral research fellow at the Brain Dynamics Centre, Westmead Hospital and the School of Physics, University of Sydney, Australia. This objective has been approached through mathematical models of neural activity and novel methods for EEG and functional neuroimaging data analysis. He works in collaboration with local researchers in Sydney and scientists in Amsterdam and the United Kingdom. Michael is also the senior registrar in psychiatry at St Vincent's Hospital, Sydney where he works in addiction psychiatry, early psychosis and psychiatry of old age. In addition to his research and clinical work, Michael is interested in music, urban geography and the rights and mental health of Australia's indigenous people.

United States/Schizophrenia Category:

Michael T. Compton, M.D., M.P.H.
Assistant Professor
Dept. of Psychiatry & Behavioral Sciences
Emory University School of Medicine
Atlanta, Georgia

Title of Winning Proposal: Vulnerability Indicators and Potential Markers of Abnormal Fetal Development in Schizophrenia

Michael T. Compton, M.D., M.P.H. is Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine, where he works on an inpatient psychiatric unit at Grady Memorial Hospital. He has a secondary appointment in the Department of Family and Preventive Medicine. Dr. Compton completed undergraduate education at Mary Washington College in Fredericksburg, Virginia, majoring in both biology and religion. He then attended the University of Virginia School of Medicine in Charlottesville, Virginia. After training in psychiatry at Emory University in Atlanta, he completed Emory's new two-year Postdoctoral Fellowship in Community Psychiatry / Public Health. He also completed residency training in preventive medicine. Dr. Compton's primary research interest is the early course of schizophrenia, and he plans to pursue a career in prevention-oriented schizophrenia research. He hopes to soon receive funding from the National Institute of Mental Health for a career development award to study the determinants and consequences of the duration of initial untreated psychosis. He is also very interested schizophrenia endophenotypes / vulnerability indicators. Other interests include substance abuse in the early course of schizophrenia, treatment adherence, antipsychotic-induced hyperprolactinemia and sexual side effects, and adverse health behaviors among those with severe mental illnesses.